150 related articles for article (PubMed ID: 22801027)
1. Estrogen-dependent variations in 18F-fluorodeoxyglucose uptake in uterine leiomyomas.
Lerman H; Bar-On S; Helpman L; Even-Sapir E; Grisaru D
Int J Gynecol Cancer; 2012 Sep; 22(7):1187-91. PubMed ID: 22801027
[TBL] [Abstract][Full Text] [Related]
2. Assessment of fluorodeoxyglucose uptake by leiomyomas in relation to histopathologic subtype and the menstrual state.
Yoshida Y; Tsujikawa T; Kurokawa T; Tsuji T; Imamura Y; Fujibayashi Y; Okazawa H; Kotsuji F
J Comput Assist Tomogr; 2009; 33(6):877-81. PubMed ID: 19940654
[TBL] [Abstract][Full Text] [Related]
3. High metabolic characteristics of uterine fibroids in 18F-FDG PET/CT imaging and the underlying mechanisms.
Ma Y; Shao X; Shao X; Wang X; Wang Y
Nucl Med Commun; 2016 Nov; 37(11):1206-11. PubMed ID: 27281358
[TBL] [Abstract][Full Text] [Related]
4. Incidence and characteristics of uterine leiomyomas with FDG uptake.
Nishizawa S; Inubushi M; Kido A; Miyagawa M; Inoue T; Shinohara K; Kajihara M
Ann Nucl Med; 2008 Nov; 22(9):803-10. PubMed ID: 19039559
[TBL] [Abstract][Full Text] [Related]
5. F-18 FDG PET in detecting uterine leiomyoma.
Lin CY; Ding HJ; Chen YK; Liu CS; Lin CC; Kao CH
Clin Imaging; 2008; 32(1):38-41. PubMed ID: 18164393
[TBL] [Abstract][Full Text] [Related]
6. 18F-FES and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: correlation with immunohistochemical analysis.
Zhao Z; Yoshida Y; Kurokawa T; Kiyono Y; Mori T; Okazawa H
J Nucl Med; 2013 Apr; 54(4):499-506. PubMed ID: 23471314
[TBL] [Abstract][Full Text] [Related]
7. 18F-FLT PET performs better than 18F-FDG PET in differentiating malignant uterine corpus tumors from benign leiomyoma.
Yamane T; Takaoka A; Kita M; Imai Y; Senda M
Ann Nucl Med; 2012 Jul; 26(6):478-84. PubMed ID: 22477262
[TBL] [Abstract][Full Text] [Related]
8. Aberrant Hypermetabolism of Benign Uterine Leiomyoma on 18F-FDG PET/CT.
Nunes RF; Queiroz MA; Buchpiguel CA; Carvalho FM; Carvalho JP
Clin Nucl Med; 2019 Jun; 44(6):e413-e414. PubMed ID: 30985441
[TBL] [Abstract][Full Text] [Related]
9. Suppression of F-18 fluorodeoxyglucose uptake in benign uterine leiomyomas with danazol.
Tripathi M; Srivastava M; Garg G; Jaimini A; Singh N; Souza MD; Kaur P; Sharma R; Mandal A
Clin Nucl Med; 2009 Jul; 34(7):452-5. PubMed ID: 19542955
[No Abstract] [Full Text] [Related]
10. Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.
Kitajima K; Murakami K; Yamasaki E; Kaji Y; Sugimura K
Ann Nucl Med; 2008 Jul; 22(6):505-12. PubMed ID: 18670857
[TBL] [Abstract][Full Text] [Related]
11. 18F-fluorodeoxyglucose uptake in uterine leiomyomas in healthy women.
Tsukada H; Murakami M; Shida M; Kikuchi K; Watanabe M; Yasuda S; Suzuki Y
Clin Imaging; 2009; 33(6):462-7. PubMed ID: 19857807
[TBL] [Abstract][Full Text] [Related]
12. Uterine tumors: pathophysiologic imaging with 16alpha-[18F]fluoro-17beta-estradiol and 18F fluorodeoxyglucose PET--initial experience.
Tsujikawa T; Yoshida Y; Mori T; Kurokawa T; Fujibayashi Y; Kotsuji F; Okazawa H
Radiology; 2008 Aug; 248(2):599-605. PubMed ID: 18539894
[TBL] [Abstract][Full Text] [Related]
13. FDG PET for the assessment of myometrial infiltration in clinical stage I uterine corpus cancer.
Torizuka T; Nakamura F; Takekuma M; Kanno T; Ogusu T; Yoshikawa E; Okada H; Maeda M; Ouchi Y
Nucl Med Commun; 2006 Jun; 27(6):481-7. PubMed ID: 16710101
[TBL] [Abstract][Full Text] [Related]
14. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT.
Lerman H; Metser U; Grisaru D; Fishman A; Lievshitz G; Even-Sapir E
J Nucl Med; 2004 Feb; 45(2):266-71. PubMed ID: 14960646
[TBL] [Abstract][Full Text] [Related]
15. Physiological uptake of 18F-fluorodeoxyglucose in uterine endometrium and myometrium: correlation with uterine motility evaluated by cine magnetic resonance imaging.
Kido A; Nakamoto Y; Nishizawa S; Yamamoto A; Fujimoto K; Okada H; Togashi K
Acta Radiol; 2009 May; 50(4):455-61. PubMed ID: 19373569
[TBL] [Abstract][Full Text] [Related]
16. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
[TBL] [Abstract][Full Text] [Related]
17. Additional value of 16α-[18F]fluoro-17β-oestradiol PET for differential diagnosis between uterine sarcoma and leiomyoma in patients with positive or equivocal findings on [18F]fluorodeoxyglucose PET.
Yoshida Y; Kiyono Y; Tsujikawa T; Kurokawa T; Okazawa H; Kotsuji F
Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1824-31. PubMed ID: 21656049
[TBL] [Abstract][Full Text] [Related]
18. Presurgical Identification of Uterine Smooth Muscle Malignancies through the Characteristic FDG Uptake Pattern on PET Scans.
Ho KC; Dean Fang YH; Lin G; Ueng SH; Wu TI; Lai CH; Chueh HY; Chao A; Chang TC; Yen TC
Contrast Media Mol Imaging; 2018; 2018():7890241. PubMed ID: 30018513
[TBL] [Abstract][Full Text] [Related]
19. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
[TBL] [Abstract][Full Text] [Related]
20. Uptake of 2-[18F]fluoro-2-deoxy-D-glucose in uterine leiomyoma: imaging of four patients by coincidence positron emission tomography.
Ak I; Ozalp S; Yalçin OT; Zor E; Vardareli E
Nucl Med Commun; 2004 Sep; 25(9):941-5. PubMed ID: 15319600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
